Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spevigo
Pharma
Leo ponies up €90 million for Boehringer Ingelheim's Spevigo
Leo Pharma has struck a partnership with Boehringer Ingelheim, paying 90 million euros ($105 million) up front to develop and commercialize Spevigo.
Kevin Dunleavy
Jul 14, 2025 8:25am
Boehringer adds new piece to its macabre 'Unwearable Collection'
Jul 7, 2023 4:34am
Atara's first-in-class allogeneic T-cell therapy nears EU nod
Oct 14, 2022 11:18am
Boehringer Ingelheim finally has skin in the dermatology game
Sep 2, 2022 10:10am
